Evidence map›Paper›PMID 19687097›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis.

Ana Carolina Monteiro, Aline Scovino, Susane Raposo, Vinicius Mussa Gaze, Catia Cruz, Erik Svensjö, Marcelo Sampaio Narciso, Ana Paula Colombo, João B Pesquero, Eduardo Feres-Filho and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. C-reactive protein levels in hereditary angioedema.Clinical and experimental immunology · 2014
    Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. TLR2 Activation byFrontiers in immunology · 2022
    Article
  8. Association betweenFrontiers in cellular and infection microbiology · 2022
    Review
  9. Effect ofToxins · 2021
    Article
  10. Gut Serpinome: Emerging Evidence in IBD.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Kinins and Their Receptors in Infectious Diseases.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 6 countries.

Ana Carolina MonteiroCarlos Chagas Filho Institute of Biophysics, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Aline Scovino
Susane Raposo
Vinicius Mussa Gaze
Catia Cruz
Erik Svensjö
Marcelo Sampaio Narciso
Ana Paula Colombo
João B Pesquero
Eduardo Feres-Filho
Ky-Anh Nguyen
Aneta Sroka
Jan Potempa
Julio Scharfstein
Czech Academy of Sciences, Institute of Biophysics · CZJagiellonian University · PLInstitute of Biomedical Science · GBThe University of Sydney · AUUniversidade Federal de São Paulo · BRUniversidade Federal do Rio de Janeiro · BR

Funding

BACTERIAL PROTEINASES IN PERIODONTAL DISEASER01DE009761 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 1991 to 2012
$3.8M
NIDCR NIH HHS DE 09761NIDCR NIH HHS R01 DE009761
6 · The paper itself

Abstract

Porphyromonas gingivalis, a Gram-negative bacterium that causes periodontitis, activates the kinin system via the cysteine protease R-gingipain. Using a model of buccal infection based on P. gingivalis inoculation in the anterior mandibular vestibule, we studied whether kinins released by gingipain may link mucosal inflammation to T cell-dependent immunity through the activation of bradykinin B(2) receptors (B(2)R). Our data show that P. gingivalis W83 (wild type), but not gingipain-deficient mutant or wild-type bacteria pretreated with gingipain inhibitors, elicited buccal edema and gingivitis in BALB/c or C57BL/6 mice. Studies in TLR2(-/-), B(2)R(-/-), and neutrophil-depleted C57BL/6 mice revealed that P. gingivalis induced edema through the sequential activation of TLR2/neutrophils, with the initial plasma leakage being amplified by gingipain-dependent release of vasoactive kinins from plasma-borne kininogens. We then used fimbriae (Fim) Ag as a readout to verify whether activation of the TLR2-->PMN-->B(2)R axis (where PMN is polymorphonuclear neutrophil) at early stages of mucosal infection had impact on adaptive immunity. Analyzes of T cell recall responses indicated that gingipain drives B(2)R-dependent generation of IFN-gamma-producing Fim T cells in submandibular draining lymph nodes of BALB/c and C57BL/6 mice, whereas IL-17-producing Fim T cells were generated only in BALB/c mice. In summary, our studies suggest that two virulence factors, LPS (an atypical TLR2 ligand) and gingipain, forge a trans-cellular cross-talk between TLR2 and B(2)R, thus forming an innate axis that guides the development of Fim-specific T cells in mice challenged intrabuccally by P. gingivalis. Ongoing research may clarify whether kinin-driven modulation of T cell responses may also influence the severity of chronic periodontitis.

Indexed as

Adhesins, BacterialAnimalsCysteine EndopeptidasesFimbriae, BacterialGingipain Cysteine EndopeptidasesImmunityInflammationInterferon-gammaInterleukin-17KininsMiceMouth MucosaPeptide HydrolasesPorphyromonas gingivalisReceptor, Bradykinin B2Signal TransductionAdhesins, BacterialCysteine EndopeptidasesGingipain Cysteine EndopeptidasesInterferon-gammaInterleukin-17KininsPeptide HydrolasesReceptor, Bradykinin B2Tlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID19687097
PMCPMC2737602
OpenAlexW2112000513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.